McGill University’s board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government’s action is “excessive and injurious” to the university.
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada. The urgent need for rigorous, scientific drug safety research has been clearly understood for decades, but lacked national coordination until the arrival of the Canadian Network for Observational Drug Effect Studies (CNODES), which today released its first report documenting progress towards its goal of creating a fully operational system for rapid assessment of adverse drug effects in Canada.
The upcoming 1st Montreal International Conference on Clinical Reasoningwill explore the tenets of clinical reasoning in an academic context. Taking place at the Laval Campus at the Université de Montréal on October 24 and 25, 2012, participants will descend on Montreal from around the world. Distinguished plenary speakers include Dr. Kevin Eva (UBC), Dr. Sílvia Mamede (Erasmus University Rotterdam) and Dr. Steven J. Durning (Uniformed Services University).
"Despite high per-capita spending, health care in Canada consistently underperforms, according to the Commonwealth Fund, which tracks indicators for accessibility, timeliness and outcomes across a number of developed countries. The system that is straining to meet demand today will face an even higher burden in the years ahead, as the population ages. A number of Canadian business schools are looking to meet this challenge by educating future health care managers to bring new perspectives to old problems.
The Douglas Institute is proud to be one of the ten member organizations of MONTRÉAL WALKS for mental health.
MONTRÉAL WALKS for mental health is an annual event. In 2011, more than 800 people walked together as an effort to help destigmatize mental illness and collect funds to improve mental health services.
On October 14, join the Douglas Institute team, which our Executive Director, Lynne McVey, will also be part of.
Translating Cardiovascular Genome-wide Discoveries to Genomic Medicine
Perspective from the Framingham Heart Study
Dr. Christopher O'Donnell
Associate Director and Scientific Director of Genome Research, Framingham Heart Study
Senior Investigator, National Heart, Lung and Blood Institute
Associate Clinical Professor, Harvard Medical School
caroline [dot] alcaraz [at] mcgill [dot] ca ()